{"id":379842,"date":"2020-11-12T09:06:29","date_gmt":"2020-11-12T14:06:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379842"},"modified":"2020-11-12T09:06:29","modified_gmt":"2020-11-12T14:06:29","slug":"natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","title":{"rendered":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SAN CARLOS, Calif.<\/span>, <span class=\"xn-chron\">Nov. 12, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979531-1&amp;h=905054478&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2567259-1%26h%3D2342451868%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2417818-1%2526h%253D3666138566%2526u%253Dhttps%25253A%25252F%25252Fwww.natera.com%25252F%2526a%253DNatera%25252C%252BInc.%26a%3DNatera%252C%2BInc.&amp;a=Natera%2C+Inc.\" rel=\"nofollow noopener noreferrer\">Natera, Inc.<\/a><\/u>\u00a0(NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on <span class=\"xn-chron\">Thursday, November 19, 2020<\/span>, at <span class=\"xn-chron\">1:30 p.m. PT<\/span> (<span class=\"xn-chron\">4:30 p.m. ET<\/span>).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg\" title=\"Natera, Inc. Logo (PRNewsFoto\/Natera, Inc.)\" alt=\"Natera, Inc. Logo (PRNewsFoto\/Natera, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <span class=\"xn-person\">Mike Brophy<\/span>, Chief Financial Officer, will discuss Natera&#8217;s latest developments and business activities.<\/p>\n<p>Access to the live webcast and subsequent archived presentation will be available at <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979531-1&amp;h=2558581369&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2567259-1%26h%3D59404445%26u%3Dhttp%253A%252F%252Finvestor.natera.com%252F%26a%3Dinvestor.natera.com.%2B&amp;a=investor.natera.com.\" rel=\"nofollow noopener noreferrer\">investor.natera.com.<\/a><\/u><\/p>\n<p>\n        <b>About Natera<br \/><\/b><br \/>\n        <u><br \/>\n          <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979531-1&amp;h=557331328&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2837094-1%26h%3D2305986283%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2818126-1%2526h%253D3703159391%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2676832-1%252526h%25253D4130479052%252526u%25253Dhttp%2525253A%2525252F%2525252Fwww.natera.com%2525252F%252526a%25253DNatera%2526a%253DNatera%26a%3DNatera&amp;a=Natera\" rel=\"nofollow noopener noreferrer\">Natera<\/a><br \/>\n        <\/u>\u00a0is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women&#8217;s health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in <span class=\"xn-location\">San Carlos, California<\/span>. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979531-1&amp;h=3277879633&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2837094-1%26h%3D2528648270%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2818126-1%2526h%253D2717552065%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2676832-1%252526h%25253D2185316474%252526u%25253Dhttp%2525253A%2525252F%2525252Fwww.natera.com%2525252F%252526a%25253D%252525C2%252525A0natera.com%2526a%253Dnatera.com%26a%3Dnatera.com&amp;a=natera.com\" rel=\"nofollow noopener noreferrer\">natera.com<\/a><\/u>. Follow Natera on <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979531-1&amp;h=2564918148&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2837094-1%26h%3D2648637082%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2818126-1%2526h%253D2455241333%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D2676832-1%252526h%25253D4200851928%252526u%25253Dhttps%2525253A%2525252F%2525252Fwww.linkedin.com%2525252Fcompany%2525252Fnatera%2525252F%252526a%25253D%252525C2%252525A0LinkedIn%2526a%253DLinkedIn%26a%3DLinkedIn&amp;a=LinkedIn\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a><\/u>.\u00a0<\/p>\n<p>\n        <b>Contacts<br \/><\/b>Investor Relations: <span class=\"xn-person\">Mike Brophy<\/span>, CFO, Natera, Inc., 510-826-2350<br \/>Media: <span class=\"xn-person\">Paul Greenland<\/span>, VP of Corporate Marketing, Natera, Inc., <a href=\"mailto:pr@natera.com\" rel=\"nofollow\">pr@natera.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF89429&amp;sd=2020-11-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/natera-to-present-at-the-canaccord-genuity-virtual-medtech--diagnostics-forum-301171568.html\">http:\/\/www.prnewswire.com\/news-releases\/natera-to-present-at-the-canaccord-genuity-virtual-medtech&#8211;diagnostics-forum-301171568.html<\/a><\/p>\n<p>SOURCE  Natera, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF89429&amp;Transmission_Id=202011120903PR_NEWS_USPR_____SF89429&amp;DateId=20201112\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN CARLOS, Calif., Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Natera, Inc.\u00a0(NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET). Mike Brophy, Chief Financial Officer, will discuss Natera&#8217;s latest developments and business activities. Access to the live webcast and subsequent archived presentation will be available at investor.natera.com. About Natera Natera \u00a0is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women&#8217;s health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379842","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN CARLOS, Calif., Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Natera, Inc.\u00a0(NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET). Mike Brophy, Chief Financial Officer, will discuss Natera&#8217;s latest developments and business activities. Access to the live webcast and subsequent archived presentation will be available at investor.natera.com. About Natera Natera \u00a0is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women&#8217;s health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited &hellip; Continue reading &quot;Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T14:06:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\",\"datePublished\":\"2020-11-12T14:06:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"wordCount\":219,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/286881\\\/Natera_Inc___Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"name\":\"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/286881\\\/Natera_Inc___Logo.jpg\",\"datePublished\":\"2020-11-12T14:06:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/286881\\\/Natera_Inc___Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/286881\\\/Natera_Inc___Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_locale":"en_US","og_type":"article","og_title":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","og_description":"PR Newswire SAN CARLOS, Calif., Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Natera, Inc.\u00a0(NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET). Mike Brophy, Chief Financial Officer, will discuss Natera&#8217;s latest developments and business activities. Access to the live webcast and subsequent archived presentation will be available at investor.natera.com. About Natera Natera \u00a0is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women&#8217;s health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited &hellip; Continue reading \"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T14:06:29+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum","datePublished":"2020-11-12T14:06:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"wordCount":219,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","name":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg","datePublished":"2020-11-12T14:06:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/286881\/Natera_Inc___Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Natera to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379842"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}